Laureate Pharma L.P. and Southern Research Institute have initiated a strategic collaboration agreement related to developing and manufacturing drug-delivery products using Southern Research’s proprietary microencapsulation process technologies.
Under the agreement, Laureate Pharma and Southern Research will collaborate to provide pharmaceutical clients with full microencapsulation services that range from development through commercial scale manufacturing.
Terms of the agreement were not disclosed.
“We are very excited about this agreement and look forward to working closely with Southern Research Institute to expand our client offerings,” said Ernest R. Tyler, Sr. Director Parenteral Production of Laureate Pharma.
Added Robert J. Broeze, Ph.D., President of Laureate Pharma, “This collaboration allows Laureate Pharma and Southern Research Institute to play a significant role in offering complete contract research and manufacturing services to the pharmaceutical industry. The agreement is an important step in Laureate Pharma’s longer term vision.”
“Laureate Pharma’s manufacturing facility is now configured to produce, on a commercial scale, injectable, depot formulations based on Southern Research’s patented microencapsulation technology. This gives us an outstanding opportunity to offer our clients expertise in microencapsulation scale-up at a commercial level as well as offering excellent manufacturing capabilities,” said Thomas R. Tice, Ph.D., Director Pharmaceutical Formulations, Southern Research Institute.
Southern Research Institute is an independent, not-for- profit center for scientific research affiliated with the University of Alabama at Birmingham.
Institute scientists are pioneers in the development of depot formulations: injectable microspheres and implantable rods.
Laureate Pharma L.P. is a privately held contract manufacturing services company dedicated to supporting the development and commercialization of pharmaceutical products for small to large pharmaceutical and biopharmaceutical companies.